Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Genomic Health, Inc.    GHDX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/13/2017 02/14/2017 02/15/2017 02/16/2017 02/17/2017 Date
27.97(c) 28.23(c) 31.12(c) 28.5(c) 29.11(c) Last
65 671 109 635 419 857 203 112 157 441 Volume
-0.39% +0.93% +10.24% -8.42% +2.14% Change
More quotes
Financials ($)
Sales 2017 358 M
EBIT 2017 1,04 M
Net income 2017 1,92 M
Finance 2017 55,5 M
Yield 2017 -
Sales 2018 400 M
EBIT 2018 14,7 M
Net income 2018 14,5 M
Finance 2018 69,8 M
Yield 2018 -
P/E ratio 2017 817,70
P/E ratio 2018 72,59
EV / Sales2017 2,57x
EV / Sales2018 2,26x
Capitalization 975 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
02/16 GENOMIC HEALTH : Four New Studies of Oncotype DX® Genomic Prostate Score™ ..
02/16 GENOMIC HEALTH : Four New Studies of Oncotype DX® Genomic Prostate Score(TM) (GP..
02/15 GENOMIC HEALTH,INC. (NASDAQ : GHDX) Files An 8-K Results of Operations and Finan..
02/14 GENOMIC HEALTH : tops 4Q profit forecasts
02/14 GENOMIC HEALTH INC : Results of Operations and Financial Condition, Financial St..
02/14 GENOMIC HEALTH : Announces 2016 Fourth Quarter and Year-End Financial Results, P..
02/07 GENOMIC HEALTH : to Announce Fourth Quarter and Year-End 2016 Financial Results ..
01/25 GENOMIC HEALTH : MILITARY $53,408 Federal Contract Awarded to Genomic Health
01/03 GENOMIC HEALTH : to Present at the 35th Annual J.P. Morgan Healthcare Conference
2016 GENOMIC HEALTH : Announces Inclusion of Oncotype DX® in the 8th Edition of Ameri..
More news
Sector news : Biotechnology & Medical Research - NEC
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
02/13 TEVA PHARMACEUTICAL INDUSTRIES : seeks CEO with pharma background to lead recove..
02/09DJAppeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug
02/08 Weak pound buoys GSK but drugmaker warns on 2017 generic threat
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
02/18Genomic Health, Inc. $GHDX Insider Sells $75,074.55 in Stock  
02/17Zacks Investment Research Upgrades Genomic Health, Inc. $GHDX to Hold  
02/16Genomic Health, Inc. $GHDX Lifted to Hold at Zacks Investment Research  
02/16Genomic Health Release: Four New Studies Of Oncotype DX Genomic Prostate Scor.. 
02/16BRIEF-Genomic Health says new studies of Oncotype DX GPS reconfirm test value.. 
More tweets
Qtime:15
News from SeekingAlpha
02/14 Genomic Health's (GHDX) CEO Kim Popovits on Q4 2016 Results - Earnings Call T..
02/14 Genomic Health beats by $0.05, misses on revenue
02/13 Notable earnings after Tuesday?s close
01/18 Premarket analyst action - healthcare
2016 Genomic Health's Oncotype DX test included in latest cancer staging manual
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends GENOMIC HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 32,3 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kimberly J. Popovits Chairman, President & Chief Executive Officer
G. Bradley Cole Chief Operating & Financial Officer
Steven Shak Chief Scientific Officer
Phillip G. Febbo Chief Medical Officer
Amy P. Sing Senior Director-Medical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GENOMIC HEALTH, INC.-0.95%975
INCYTE CORPORATION20.17%22 822
QUINTILES IMS HOLDINGS..0.92%18 894
CELLTRION, INC.--.--%10 747
LONZA GROUP AG1.87%10 368
SEATTLE GENETICS, INC.24.12%9 272
More Results